Business: Swiss phase 2 biotech developing next generation drugs for cancer. NOVUS Capital Corp - Indianapolis, Ind. - 10 million shares, priced at $10 ...
News
- Initial public offerings scheduled to debut next week
- Correction: Earns-Salarius story
The biotech drug developer posted revenue of $1.1 million in the period. In the final minutes of trading on Thursday, the company's shares hit 84 cents. A ...
- Snohomish County health officials probe positive blood tests
... Dr. Jared Roach, a senior research scientist at the Institute for Systems Biology, a Seattle-based biomedical research firm, told the newspaper.
- Whistleblower: US still lacks virus plan, Americans at risk
Bright, a career official, alleges he was removed as head of the Biomedical Advanced Research and Development Authority after repeatedly warning ...
- Sanofi walks back after saying US would get vaccine first
The Biomedical Advanced Research and Development Authority has funded the development of the vaccine. Sanofi pushed for “similar measures” ...